PRehabilitiation in Elective Frail and Elderly Cardiac Surgery PaTients (PREFECT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03399162 |
|
Recruitment Status :
Withdrawn
(Due to a reduction in surgical wait times, there was insufficient time to complete the intervention prior to surgery.)
First Posted : January 16, 2018
Last Update Posted : June 20, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Coronary Artery Disease Valvular Heart Disease | Behavioral: PREHAB Workshop Behavioral: PREHAB Exercise Program | Not Applicable |
Frailty is a common syndrome among older adults, defined as a "clinically recognizable state of increased vulnerability resulting from aging-associated decline in reserve and function". Fried defined frailty as meeting three out of the five criteria: low grip strength, low energy, slowed walking speed, low physical activity, and/or unintentional weight loss. Clinicians are currently challenged with a rising prevalence of elderly and frail patients presenting for major cardiac surgery. Such patients typically present with a greater comorbidity burden and are more likely to be malnourished, physically deconditioned, and to exhibit decreased physiological adaptation to stress. Frail cardiac surgical patients are, unsurprisingly, at increased risk for major adverse cardiac and cerebrovascular events, short- and longer-term mortality, and increased length of hospital of stay. Clinicians may also struggle to quantify the peri-operative risk of morbidity and mortality among these individuals, since tools such as the Society of Thoracic Surgeons (STS) risk assessment are not designed to comprehensively assess the complex interaction between various risk factors seen in the frail patient.
Cardiovascular rehabilitation (CR) programs are integral to managing patients with cardiovascular disease. Such programs include health behaviour change, and cardiovascular risk factor management (e.g. moderate-to-vigorous-intensity continuous exercise training [MICE], healthy eating, smoking cessation, stress management, and psychological services). The benefits of MICE for patients with cardiovascular disease include improvements in exercise tolerance, muscular strength, cardiovascular health and reduced hospitalizations. MICE is, therefore, able to improve several facets of physical dysfunction, and forms major therapeutic interventions for functional capacity and frailty. Improvements in nutritional status have been observed in patients with cardiovascular disease(CVD) participating in CR, and exercise training and stress management have been shown to reduce distress in CVD patients.
Emerging evidence indicates that CR before cardiac surgery (i.e. prehabilitation [PREHAB]) may improve clinical outcomes. Sawatzky et al. showed that a 12-week PREHAB program consisting of two structured exercise training sessions per week and 12 education sessions concerning cardiovascular risk factor management, exercise, stress, diet, and medication use in patients awaiting coronary artery bypass grafting (CABG) was feasible and significantly improved functional capacity.
Elderly and frail patients are increasingly presenting for cardiac surgery, and these individuals must be carefully optimized pre-operatively to increase the likelihood of their recovery and return to a reasonable quality of life. A personalized PREHAB program that targets and ameliorates the elements of frailty, including low functional capacity, poor nutrition, and stress, offers the best chance of mitigating frailty and its associated risk factors in a way that is feasible, patient-centred, and translatable to other cardiovascular centres. This project will use objective measures, including tests of functional capacity, validated questionnaires, and biomarker analysis, to better quantify the subjective diagnosis of frailty in our patients, and will implement a novel personalized PREHAB program with integrated on-site and home-based exercise sessions, in an attempt to mitigate the frailty and other risk factors that impact patients in the peri-operative period.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 0 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Prevention |
| Official Title: | PRehabilitiation in Elective Frail and Elderly Cardiac Surgery PaTients (PREFECT): Assessing the Impact of a Personalized Prehabilitation Program Before Cardiac Surgery on Frailty and Clinical Outcomes |
| Actual Study Start Date : | May 20, 2018 |
| Actual Primary Completion Date : | May 1, 2019 |
| Estimated Study Completion Date : | August 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: PREHAB Group
Patients in this arm will receive the usual standard of care prior to surgery, which includes a PREHAB workshop; consultations with a surgeon, anaesthesiologist, and nurse; referrals to diabetes counselling and/or smoking cessation, as appropriate; and the usual diagnostic work-up. Patients in this group will also complete an 8-week PREHAB exercise program, with weekly exercise classes and a list of exercises to complete at home. |
Behavioral: PREHAB Workshop
PREHAB workshop/education session in the Prevention and Rehabilitation Centre regarding nursing, nutrition, physiotherapy, psychology, and diabetes. Behavioral: PREHAB Exercise Program An 8-week program that consists of: (1) 2x/week 60-minute supervised exercise sessions; and (2) 3x/week 30-minute home-based exercise sessions. |
|
Active Comparator: Standard of care group
Patients in this arm will receive the usual standard of care prior to surgery, which includes a PREHAB workshop; consultations with a surgeon, anaesthesiologist, and nurse; referrals to diabetes counselling and/or smoking cessation, as appropriate; and the usual diagnostic work-up.
|
Behavioral: PREHAB Workshop
PREHAB workshop/education session in the Prevention and Rehabilitation Centre regarding nursing, nutrition, physiotherapy, psychology, and diabetes. |
- Functional capacity [ Time Frame: Change between baseline and 8 weeks (+/- 1 week) ]The primary outcome, functional capacity, will be measured using the 6-minute walk test.
- Frailty (Fried criteria) [ Time Frame: Compared between baseline, 8 weeks (+/- 1 week), and 4 weeks after surgery (+/- 2 weeks) ]Measured using the Fried frailty score (presence of 3 of the 5 symptoms of frailty)
- Frailty (clinical score) [ Time Frame: Compared between baseline, 8 weeks (+/- 1 week), and 4 weeks after surgery (+/- 2 weeks) ]Measured using the Clinical Frailty Scale (9 point clinical assessment)
- Short Form - 36 [ Time Frame: Compared between baseline, 8 weeks (+/- 1 week), and 4 weeks after surgery (+/- 2 weeks) ]Measured using the SF-36 Quality of Life questionnaire
- Depression [ Time Frame: Compared between baseline, 8 weeks (+/- 1 week), and 4 weeks after surgery (+/- 2 weeks) ]Measured using the BDI-II
- Anxiety [ Time Frame: Compared between baseline, 8 weeks (+/- 1 week), and 4 weeks after surgery (+/- 2 weeks) ]Measured using the BAI
- Dietary habits [ Time Frame: Compared between baseline, 8 weeks (+/- 1 week), and 4 weeks after surgery (+/- 2 weeks) ]Measured using the Block food frequency questionnaire
- Exercise adherence [ Time Frame: Compared between baseline and 8 weeks (+/- 1 week) ]Measured using a pedometer
- Clinical and cardiovascular outcomes [ Time Frame: In the 6 weeks after surgery ]A composite endpoint that will look at the rates of occurrence of major cardiovascular and cerebrovascular outcomes (i.e. death, myocardial infarction, cardiac arrest, stroke) and length of hospitalization.
- Biomarkers [ Time Frame: Compared between baseline and 8 weeks (+/- 1 week) ]An exploratory outcome where we will examine a panel of biomarkers to determine the biomarker profile of frail and elderly patients referred for cardiac surgery, and to observe what changes, if any, occur after the PREHAB intervention. The biomarker panel includes markers of cardiovascular health and risk (NT-pro BNP, cholesterol, homocysteine), nutritional status (albumin, prealbumin, trasnferrin receptor, 25-hydroxy-vitamin D), inflammation (interleukin 6, selenium, high sensitivity CRP, sRAGE), renal function (creatinine, cystatin C), liver function (AST, ALT), and overall health (CBC, adiponectin, dehydroepiandrosterone sulfate, sex hormone-binding globulin, insulin-like growth factor).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients >18 years of age
- Patients able to provide informed consent
- Patients undergoing elective cardiac surgery for either CABG, valve, or CABG + valve
- Patients who have an estimated wait time of at least 10 weeks.
- Patients who are either ≥65 years of age or classified as frail using Fried Frailty criteria or scoring at least 3 on the Clinical Frailty Scale
Exclusion Criteria:
- Patients with current or recent unstable cardiac disease, defined as and of the following:
- CCS class IV angina,
- NYHA Class III or IV heart failure,
- Critical left main disease,
- hospitalization for arrhythmia within the last month
- Dynamic ventricular outflow obstruction
- Symptomatic exercise-induced arrhythmia
- Patients who are cognitively, geographically or physically unable to complete the PREHAB sessions
- Patients who, in the opinion of either their treating physician or the study investigators, should not participate in a pre-operative rehabilitation program.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03399162
| Canada, Ontario | |
| University of Ottawa Heart Institute | |
| Ottawa, Ontario, Canada, K1Y4W7 | |
| Principal Investigator: | Juan B Grau Alvaro, MD | Ottawa Heart Institute Research Corporation | |
| Principal Investigator: | Louise Sun, MD | Ottawa Heart Institute Research Corporation | |
| Principal Investigator: | Jennifer Reed, PhD | Ottawa Heart Institute Research Corporation |
| Responsible Party: | Ottawa Heart Institute Research Corporation |
| ClinicalTrials.gov Identifier: | NCT03399162 |
| Other Study ID Numbers: |
20170698 |
| First Posted: | January 16, 2018 Key Record Dates |
| Last Update Posted: | June 20, 2019 |
| Last Verified: | June 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Coronary Artery Disease Heart Diseases Heart Valve Diseases Coronary Disease Myocardial Ischemia |
Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases |

